Latest Ratios: P/E Ratio 101.3x · EV/EBITDA 33.6x · ROE 3.2%. (2009–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $2.1B | $1.2B | $986M | $1.0B | $700M | $1.4B | $4.1B | $2.7B | $3.1B | $2.8B | $1.4B |
| Enterprise Value | $2.0B | $1.1B | $900M | $943M | $665M | $1.4B | $4.0B | $2.6B | $3.0B | $2.7B | $1.3B |
| P/E Ratio → | 101.28 | 57.49 | 59.23 | 59.03 | — | 42.44 | 81.16 | 43.21 | 40.14 | 53.37 | 31.89 |
| P/S Ratio | 3.98 | 2.30 | 1.97 | 2.03 | 1.43 | 2.91 | 9.50 | 5.99 | 6.90 | 8.03 | 4.58 |
| P/B Ratio | 3.22 | 1.83 | 1.47 | 1.47 | 1.00 | 1.71 | 6.40 | 4.69 | 5.68 | 6.00 | 3.59 |
| P/FCF | 35.55 | 20.56 | 14.35 | 22.62 | 17.32 | 67.51 | 68.81 | 51.04 | 85.88 | 56.30 | 32.99 |
| P/OCF | 28.46 | 16.46 | 12.66 | 13.94 | 11.27 | 25.70 | 38.57 | 23.67 | 25.03 | 33.82 | 18.20 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.10 | 1.80 | 1.87 | 1.36 | 2.79 | 9.23 | 5.74 | 6.71 | 7.93 | 4.35 |
| EV / EBITDA | 33.57 | 18.67 | 14.68 | 14.31 | 10.01 | 19.93 | 43.40 | 23.79 | 25.87 | 30.14 | 16.34 |
| EV / EBIT | 76.89 | 36.07 | 36.18 | 32.47 | — | 33.88 | 63.73 | 32.44 | 32.64 | 36.72 | 20.17 |
| EV / FCF | — | 18.78 | 13.11 | 20.89 | 16.45 | 64.73 | 66.91 | 48.93 | 83.51 | 55.65 | 31.32 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 44.5% | 44.5% | 44.6% | 44.1% | 44.1% | 45.6% | 50.1% | 51.3% | 53.6% | 56.3% | 56.0% |
| Operating Margin | 4.9% | 4.9% | 5.1% | 5.6% | 5.5% | 5.7% | 13.8% | 17.4% | 20.0% | 21.0% | 20.7% |
| Net Profit Margin | 4.0% | 4.0% | 3.3% | 3.4% | -21.2% | 6.8% | 11.7% | 13.9% | 17.2% | 15.0% | 14.3% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 3.2% | 3.2% | 2.4% | 2.5% | -13.6% | 4.5% | 8.3% | 11.3% | 15.3% | 12.3% | 12.1% |
| ROA | 2.8% | 2.8% | 2.2% | 2.2% | -12.0% | 4.0% | 7.2% | 9.8% | 13.5% | 11.1% | 11.0% |
| ROIC | 3.4% | 3.4% | 3.2% | 3.3% | 2.8% | 3.2% | 9.0% | 12.9% | 15.1% | 14.6% | 15.7% |
| ROCE | 3.8% | 3.8% | 3.6% | 3.9% | 3.4% | 3.6% | 9.1% | 13.4% | 17.1% | 16.7% | 17.0% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.01 | 0.02 | 0.02 | — | 0.01 | — |
| Debt / EBITDA | 0.08 | 0.08 | 0.06 | 0.08 | 0.32 | 0.11 | 0.14 | 0.11 | — | 0.06 | — |
| Net Debt / Equity | — | -0.16 | -0.13 | -0.11 | -0.05 | -0.07 | -0.18 | -0.19 | -0.16 | -0.07 | -0.18 |
| Net Debt / EBITDA | -1.77 | -1.77 | -1.40 | -1.19 | -0.53 | -0.86 | -1.24 | -1.02 | -0.74 | -0.35 | -0.87 |
| Debt / FCF | — | -1.78 | -1.25 | -1.73 | -0.87 | -2.78 | -1.91 | -2.11 | -2.37 | -0.65 | -1.66 |
| Interest Coverage | — | — | 124.36 | 26.41 | — | — | — | — | — | — | — |
Net cash position: cash ($111M) exceeds total debt ($5M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.49 | 3.49 | 3.66 | 4.04 | 2.61 | 3.34 | 4.82 | 4.97 | 4.08 | 3.89 | 6.74 |
| Quick Ratio | 3.27 | 3.27 | 3.43 | 3.76 | 2.42 | 3.10 | 4.60 | 4.76 | 3.89 | 3.63 | 6.34 |
| Cash Ratio | 1.91 | 1.91 | 1.94 | 2.07 | 1.12 | 1.41 | 3.22 | 3.38 | 2.50 | 2.22 | 4.62 |
| Asset Turnover | — | 0.70 | 0.67 | 0.65 | 0.61 | 0.53 | 0.58 | 0.68 | 0.72 | 0.67 | 0.72 |
| Inventory Turnover | 20.55 | 20.55 | 22.57 | 20.64 | 20.10 | 20.17 | 19.94 | 22.18 | 20.51 | 13.37 | 14.08 |
| Days Sales Outstanding | — | 55.75 | 50.58 | 54.38 | 59.99 | 60.85 | 49.08 | 45.71 | 53.17 | 56.51 | 42.26 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 1.0% | 1.7% | 1.7% | 1.7% | — | 2.4% | 1.2% | 2.3% | 2.5% | 1.9% | 3.1% |
| FCF Yield | 2.8% | 4.9% | 7.0% | 4.4% | 5.8% | 1.5% | 1.5% | 2.0% | 1.2% | 1.8% | 3.0% |
| Buyback Yield | 2.0% | 3.5% | 6.1% | 4.3% | 4.2% | 1.6% | 0.4% | 1.2% | 0.4% | 0.2% | 0.0% |
| Total Shareholder Yield | 2.0% | 3.5% | 6.1% | 4.3% | 4.2% | 1.6% | 0.4% | 1.2% | 0.4% | 0.2% | 0.0% |
| Shares Outstanding | — | $24M | $25M | $26M | $27M | $28M | $27M | $27M | $27M | $27M | $27M |
Includes 30+ ratios · 17 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying PRLB stock.
Proto Labs, Inc.'s current P/E ratio is 101.3x. The historical average is 49.1x. This places it at the 100th percentile of its historical range.
Proto Labs, Inc.'s current EV/EBITDA is 33.6x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 22.4x.
Proto Labs, Inc.'s return on equity (ROE) is 3.2%. The historical average is 31.6%.
Based on historical data, Proto Labs, Inc. is trading at a P/E of 101.3x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Proto Labs, Inc. has 44.5% gross margin and 4.9% operating margin.
Proto Labs, Inc.'s Debt/EBITDA ratio is 0.1x, indicating low leverage. A ratio below 2x is generally considered financially healthy.
Key Metrics
Top Statement Risk
Network segment margin dilution
Metrics are mathematically derived from official filings.
Margin Expansion Signals Mix Shift
Gross margin expanded to 46.4% in 2026Q2 from 44.3% a year earlier, as reported in financial statements, suggesting a favorable mix shift toward higher-margin in-house services and improved pricing power.
The 210 basis point year-over-year gross margin improvement, coupled with operating margin nearly doubling to 7.6%, indicates that the company is finally realizing operating leverage after years of heavy investment in its digital platform. However, the persistence of a ~38 percentage point gap between gross and operating margins suggests that SG&A and R&D costs remain structurally high, likely reflecting the ongoing need to maintain the proprietary software and sales infrastructure. Investors should monitor whether this margin expansion is durable or a one-quarter effect driven by project mix.
ROIC Inflection Points to Efficiency Gains
ROIC improved to 1.5% in 2026Q2 from 0.8% a year earlier, based on reported figures, suggesting that the company is beginning to generate better returns on its invested capital after a period of stagnation.
The doubling of ROIC from 0.7% in 2025Q2 to 1.5% in 2026Q2, while still low in absolute terms, indicates that the asset base is becoming more productive. This improvement is driven primarily by margin expansion rather than asset turnover, which has remained flat at 0.19x. The low ROIC relative to the cost of capital suggests that the company is still in the early stages of monetizing its heavy investments in manufacturing capacity and software, and investors should watch whether this trend can be sustained as revenue growth continues.
Working Capital Cycle Lengthens Slightly
The cash conversion cycle extended to 50 days in 2026Q2 from 49 days a year earlier, as per financial statements, reflecting a modest increase in days sales outstanding to 56 days.
The slight lengthening of the CCC, driven by DSO increasing from 52 to 56 days year-over-year, suggests that the company may be extending payment terms to larger customers as part of its strategic pivot toward bigger accounts. DIO and DPO have remained stable, indicating that inventory management and supplier relationships are not the primary drivers of working capital changes. The increase in DSO, while small, warrants monitoring as it could signal a shift in customer mix toward larger, slower-paying enterprises, which may have implications for cash flow timing.
Debt-Free Balance Sheet Preserves Optionality
Proto Labs maintains a near-zero debt profile with a D/E ratio of 0.00 and D/EBITDA of 0.12 in 2026Q2, according to recent filings, providing a fortress-like balance sheet that minimizes refinancing risk.
The company's minimal debt, down from $5.0M in 2024Q1 to $2.2M in 2026Q2, underscores a conservative capital structure that allows management to weather cyclical downturns and invest in growth initiatives without the burden of interest expense. Interest coverage is effectively infinite given the negligible debt, but the low D/EBITDA ratio suggests that even if the company were to lever up, it would have substantial capacity. This financial flexibility is particularly valuable given the cyclicality of the prototyping business and the ongoing strategic pivot toward larger customers.
Ample Liquidity Buffers Against Volatility
The current ratio improved to 3.64 in 2026Q2 from 3.60 a year earlier, with cash of $127.9M, as reported in the balance sheet, providing a strong buffer against working capital swings.
With a quick ratio of 3.43, the company's liquidity position is exceptionally strong, and it could cover its current liabilities more than three times over without relying on inventory sales. This ample liquidity is critical given the lumpy cash flow patterns observed in the prior cash flow analysis, where free cash flow swung from $30.4M to $9.2M quarter-over-quarter. The fortress-like balance sheet, combined with near-zero debt, suggests that Proto Labs is well-positioned to fund its strategic initiatives and withstand potential demand shocks without external financing.
P/E Misleads on Growth Potential
The trailing P/E of 91.19 appears extreme, but forward P/E of 39.69, based on reported figures, suggests the market is pricing in significant earnings growth, making the metric less meaningful for this asset-heavy digital manufacturer.
The most commonly misapplied ratio for Proto Labs is the trailing P/E, which is distorted by the company's historically low earnings base and significant stock-based compensation. A more appropriate valuation metric is EV/EBITDA, which at 30.05x still appears rich but better captures the company's cash-generating ability and its capital structure. Additionally, investors should consider the price-to-sales ratio of 3.58x, which, when compared to the company's accelerating revenue growth, may indicate that the market is pricing in a sustained recovery in profitability. The wide gap between trailing and forward earnings multiples highlights the market's expectation of a sharp earnings inflection, which is not yet fully reflected in historical ratios.